Influencing factors of postpartum abnormal glucose metabolism outcomes among patients with gestational diabetes mellitus
Zhang Jiani,Mao Chihui,Cao Qi,Wang Xiaodong
DOI: https://doi.org/10.3877/cma.j.issn.1673-5250.2022.01.007
2022-01-01
Abstract:Objective:To explore postpartum abnormal glucose metabolism (AGM) outcomes and its influencing factors of patients with gestational diabetes mellitus (GDM).Methods:From January to December 2019, a total of 1 175 GDM patients with singleton pregnancy who delivered in West China Second University Hospital, Sichuan University and screened glucose by performing 75 g oral glucose tolerance test (OGTT) from 4 to 12 weeks postpartum were selected as research subjects. According to whether their postpartum glucose metabolism was normal or not, they were divided into study group (n=361, with postpartum AGM) and control group (n=814, with normal postpartum glucose metabolism). Retrospective research methods were used to analyze clinical data during pregnancy, such as general information and 75 g OGTT results during pregnancy and 4-12 weeks postpartum, and so on. Independent-samples t test or chi-square test was used to conduct univariate analysis on influencing factors of postpartum AGM in GDM patients; and with combination of previous research results and clinical experience, as well as the above univariate analysis results, multivariate unconditional logistic regression analysis was further conducted to explore independent influencing factors of postpartum AGM in patients with GDM. This study was approved by the Ethics Committee of West China Second University Hospital, Sichuan University [Approval No. 2021(181)].Results:①Results of 75 g OGTT at 24-28 gestational weeks showed that there were 639 cases (54.4%), 373 cases (31.7%) and 163 caes (13.9%) patients with 1, 2 and 3 elevated blood glucose values in FPG and OGTT 1 h and 2 h, respectively. ②Results of postpartum glucose from 4 to 12 weeks showed that patients with normal postpartum glucose metabolism accounted for 69.3% (814/1 175), while patients with AGM accounted for 30.7% (361/1 175), including 19 cases (1.6%) of impaired fasting glucose (IFG), 294 cases (25.0%) of impaired glucose tolerance (IGT), 23 cases (2.0%) of IFG+ IGT, and 25 cases (2.1%) of suspected type 2 diabetes mellitus (T2DM). ③Univariate analysis results of influencing factors of postpartum AGM in GDM patients showed that age, incidence of family history of diabetes, values of OGTT 1 h and 2 h glucose at 24-28 gestational weeks, proportions of patients with two glucose values (OGTT 1 h and 2 h glucose) increasing, and three glucose values (FPG, OGTT 1 h and 2 h glucose) increasing were statistically higher than those in control group, while proportion of patients with only one glucose value increasing (FPG or OGTT 1 h glucose) was statistically lower than that in control group, and all differences were statistically significant (P<0.05). ④Multivariate unconditional logistic regression analysis: results of model 1 adjusting age, family history of diabetes, and glucose values of 75 g OGTT at 24-28 gestational weeks revealed that family history of diabetes, OGTT 1 h and 2 h glucose values were independent risk factors of postpartum AGM in GDM patients (OR=1.693, 1.205, 1.355; 95%CI: 1.208-2.373, 1.088-1.335, 1.204-1.524; P=0.002, <0.001, <0.001). Results of model 2 adjusting age, family history of diabetes, and increasing glucose items of 75 g OGTT at 24-28 gestational weeks revealed that family history of diabetes, two glucose items increasing (OGTT 1 h and 2 h glucose), and three glucose items increasing were independent risk factors of postpartum AGM in GDM patients (OR=1.668, 1.421, 1.747; 95%CI: 1.192-2.333, 1.035-1.952, 1.195-2.553; P=0.003, 0.030, 0.004). Only FPG or OGTT 1 h glucose increasing were independent protective factors of postpartum AGM in GDM patients (OR=0.401, 0.646; 95%CI: 0.240-0.670, 0.418-0.997; P<0.001, =0.048).Conclusions:For postpartum AGM in patients with GDM, clinical attention should be paid to indicators, such as age, family history of diabetes, and OGTT results during pregnancy. Targeting high-risk populations for continuous monitoring and standardized interventions for above indicators are critical steps in managing GDM from pre-pregnancy period to postpartum.